Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention

American Journal of Cardiology

Volumn 109, Issue 4, 2012, Pages 478-485

  Chan, William ^a   Stub, Dion ^a   Clark, David J ^b   Ajani, Andrew E ^c,d,g   Andrianopoulos, Nick ^d   Brennan, Angela L ^d   New, Gishel ^e   Black, Alexander ^c,d,f,g   Shaw, James A ^a   Reid, Christopher M ^d   Dart, Anthony M ^a   Duffy, Stephen J ^a,d  

^a ALFRED HOSPITAL   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e BOX HILL HOSPITAL   (Australia)

^f GEELONG HOSPITAL   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ADVERSE OUTCOME; AORTA BALLOON; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; ANGIOPLASTY, BALLOON, CORONARY; AUSTRALIA; COHORT STUDIES; CORONARY ARTERY DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSTHESIS DESIGN; REGISTRIES; RETREATMENT; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; STENTS; STROKE VOLUME;

EID: 84856442223     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.09.037     Document Type: Article

References (26)

1. I. Morishima, T. Sone, K. Okumura, H. Tsuboi, J. Kondo, H. Mukawa, H. Matsui, Y. Toki, T. Ito, T. Hayakawa Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction J Am Coll Cardiol 36 2000 1202 1209
2. G. Ndrepepa, K. Tiroch, D. Keta, M. Fusaro, M. Seyfarth, J. Pache, J. Mehilli, A. Schmig, A. Kastrati Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction Circ Cardiovasc Interv 3 2010 27 33
3. H.K. Yip, M.C. Chen, H.W. Chang, C.L. Hang, Y.K. Hsieh, C.Y. Fang, C.J. Wu Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon Chest 122 2002 1322 1332
4. K. Iwakura, H. Ito, S. Kawano, Y. Shintani, K. Yamamoto, A. Kato, M. Ikushima, K. Tanaka, M. Kitakaze, M. Hori, Y. Higashino, K. Fujii Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction J Am Coll Cardiol 38 2001 472 477 (Pubitemid 32721776)
5. A.E. Ajani, G. Szto, S.J. Duffy, D. Eccleston, D.J. Clark, J. Lefkovits, D.P. Chew, R. Warren, A. Black, G. New, A. Walton, R. Lew, J. Shaw, M. Horrigan, M. Sebastian, B.P. Yan, A. Brennan, A. Meehan, C. Reid, H. Krum Melbourne Interventional Group Investigators The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project Heart Lung Circ 15 2006 44 47 (Pubitemid 43355906)
6. W. Chan, D.J. Clark, A.E. Ajani, C.H. Yap, N. Andrianopoulos, A.L. Brennan, D.T. Dinh, G.C. Shardey, J.A. Smith, C.M. Reid, S.J. Duffy Progress towards a National Cardiac Procedure databasedevelopment of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries Heart Lung Circ 20 2011 10 18
7. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindbck, T. Nilsson, L. Wallentin SCAAR Study Group Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019 (Pubitemid 46376801)
8. N. Andrianopoulos, D. Dinh, S.J. Duffy, D.J. Clark, A.L. Brennan, W. Chan, G.C. Shardey, J.A. Smith, C.H. Yap, B.F. Buxton, A.E. Ajani, C.M. Reid Quality control activities associated with registries in interventional cardiology and surgery Heart Lung Circ 20 2011 180 186
9. M.J. Butler, D. Eccleston, D.J. Clark, A.E. Ajani, N. Andrianopoulos, A. Brennan, G. New, A. Black, G. Szto, C.M. Reid, B.P. Yan, J.A. Shaw, A.M. Dart, S.J. Duffy Melbourne Interventional Group The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents Am Heart J 157 2009 899 907
10. TIMI Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction Results of the Thrombolysis In Myocardial Infarction (TIMI) phase II trial. The TIMI Study Group N Engl J Med 320 1989 618 627
11. R.H. Mehta, K.J. Harjai, J. Boura, D. Cox, G.W. Stone, W. O'Neill, C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) Investigators Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction Am J Cardiol 92 2003 1445 1447 (Pubitemid 37532569)
12. R.N. Piana, G.Y. Paik, M. Moscucci, D.J. Cohen, C.M. Gibson, A.D. Kugelmass, J.P. Carrozza Jr, R.E. Kuntz, D.S. Baim Incidence and treatment of "no-reflow" after percutaneous coronary intervention Circulation 89 1994 2514 2518 (Pubitemid 24173664)
13. F.S. Resnic, M. Wainstein, M.K. Lee, D. Behrendt, R.V. Wainstein, L. Ohno-Machado, J.M. Kirshenbaum, C.D. Rogers, J.J. Popma, R. Piana No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention Am Heart J 145 2003 42 46 (Pubitemid 36034496)
14. K.M. Abbo, M. Dooris, S. Glazier, W.W. O'Neill, D. Byrd, C.L. Grines, R.D. Safian Features and outcome of no-reflow after percutaneous coronary intervention Am J Cardiol 75 1995 778 782
15. C.H. Lee, H.B. Wong, H.C. Tan, J.J. Zhang, S.G. Teo, H.Y. Ong, A. Low, A. Sutandar, Y.T. Lim Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry J Interv Cardiol 18 2005 261 266 (Pubitemid 41725551)
16. L. Galiuto, A. Lombardo, A. Maseri, L. Santoro, I. Porto, D. Cianflone, A.G. Rebuzzi, F. Crea Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation Heart 89 2003 731 737 (Pubitemid 36760629)
17. R. Hoffmann, P. Haager, J. Arning, P. Christott, P. Radke, R. Blindt, J. Ortlepp, W. Lepper, P. Hanrath Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function Am J Cardiol 92 2003 1015 1019 (Pubitemid 37329523)
18. J.G. Webb, R.G. Carere, R. Virmani, D. Baim, P.S. Teirstein, P. Whitlow, C. McQueen, F.D. Kolodgie, E. Buller, A. Dodek, G.B. Mancini, S. Oesterle Retrieval and analysis of particulate debris after saphenous vein graft intervention J Am Coll Cardiol 34 1999 468 475
19. F.A. Cura, D.L. Bhatt, A.M. Lincoff, S.R. Kapadia, P.L. L'Allier, K.M. Ziada, K.E. Wolski, D.J. Moliterno, S.J. Brener, S.G. Ellis, E.J. Topol Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions Circulation 102 2000 28 34 (Pubitemid 30430549)
20. J.A. de Lemos, E.M. Antman, C.M. Gibson, C.H. McCabe, R.P. Giugliano, S.A. Murphy, S.A. Coulter, K. Anderson, J. Scherer, M.J. Frey, R. Van Der Wieken, F. Van De Werf, E. Braunwald Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction Observations from the TIMI 14 trial Circulation 101 2000 239 243 (Pubitemid 30054149)
21. E. Eeckhout, M.J. Kern The coronary no-reflow phenomenon: a review of mechanisms and therapies Eur Heart J 22 2001 729 739 (Pubitemid 32625230)
22. C.M. Gibson, A. Schmig Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion Circulation 109 2004 3096 3105
23. G. Niccoli, F. Burzotta, L. Galiuto, F. Crea Myocardial no-reflow in humans J Am Coll Cardiol 54 2009 281 292
24. K.C. Wu, E.A. Zerhouni, R.M. Judd, C.H. Lugo-Olivieri, L.A. Barouch, S.P. Schulman, R.S. Blumenthal, J.A. Lima Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772 (Pubitemid 28135339)
25. D.S. Baim, D. Wahr, B. George, M.B. Leon, J. Greenberg, D.E. Cutlip, U. Kaya, J.J. Popma, K.K. Ho, R.E. Kuntz Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290 (Pubitemid 34260417)
26. P.J. Vlaar, T. Svilaas, I.C. van der Horst, G.F. Diercks, M.L. Fokkema, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, F. Zijlstra Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous Coronary Intervention in Acute Myocardial Infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920 (Pubitemid 351778190)